{
    "clinical_study": {
        "@rank": "67195", 
        "acronym": "PENTA15", 
        "arm_group": {
            "arm_group_label": "Abacavir Once versus Twice Daily", 
            "arm_group_type": "Other", 
            "description": "This is a single arm study. Intervention 1: PK assessment while on Twice Daily Abacavir (Week 0) Intervention 2: PK assessment while on Once Daily Abacavir  (Week 4)"
        }, 
        "brief_summary": {
            "textblock": "To compare the plasma pharmacokinetic (PK) parameters of q24h versus q12h dosing of abacavir\n      in HIV-1-infected infants and children aged 3 months to 36 months\n\n      The secondary objectives of PENTA15 were:\n\n      To compare the plasma PK parameters of q24h versus q12h dosing of lamivudine in\n      HIV-1-infected infants and children aged 3 months to 36 months who were receiving lamivudine\n      in combination with abacavir\n\n      To compare age-related differences in the PK parameters of q24h versus q12h dosing of\n      abacavir and lamivudine infants and children in 3 age groups (\u22653 to <12 months, \u226512 to <24\n      months and \u226524 to <36 months)\n\n      To describe child and family acceptability of and adherence to q24h compared to q12h dosage\n      regimens of abacavir and lamivudine"
        }, 
        "brief_title": "PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "This is a single arm crossover study First intervention: PK assessment while on Twice Daily Abacavir Second intervention: PK assessment while on Once Daily Abacavir", 
                        "title": "Single Arm"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "18"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "18"
                                            }
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "8"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "10"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "3"
                                            }
                                        }, 
                                        "sub_title": "White"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "14"
                                            }
                                        }, 
                                        "sub_title": "Black, African or other"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "1"
                                            }
                                        }, 
                                        "sub_title": "Mixed Black/White"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Race/Ethnicity, Customized", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "3"
                                            }
                                        }, 
                                        "sub_title": "Germany"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "1"
                                            }
                                        }, 
                                        "sub_title": "Italy"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "9"
                                            }
                                        }, 
                                        "sub_title": "United Kingdom"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "2"
                                            }
                                        }, 
                                        "sub_title": "Spain"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "3"
                                            }
                                        }, 
                                        "sub_title": "France"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Blood samples were taken at 0 (pre-dose), 1, 2, 3, 4, 6, 8 and 12 hours post-ingestion of medication.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "This is a single arm study. First intervention: PK assessment of Twice Daily Abacavir (Week 0) Second intervention: PK assessment of Once Daily Abacavir (Week 4)", 
                                "title": "Single Arm"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "18"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "8.89", 
                                                    "@upper_limit": "13.24", 
                                                    "@value": "10.85"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Blood samples were taken at 0 (pre-dose), 1, 2, 3, 4, 6, 8 and 12 hours post-ingestion of medication.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Geometric Mean", 
                                    "title": "Area Under Curve (AUC) (0-24) of Abacavir on Twice Daily Dosing", 
                                    "units": "h*mg/L"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Week 0", 
                        "title": "Area Under Curve (AUC) (0-24) of Abacavir on Twice Daily Dosing", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Blood samples were taken at 0 (pre-dose), 1, 2, 3, 4, 6, 8 and 12 hours post-ingestion of medication.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "This is a single arm study. First intervention: PK assessment of Twice Daily Abacavir (Week 0) Second intervention: PK assessment of Once Daily Abacavir (Week 4)", 
                                "title": "Single Arm"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "18"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "1.80", 
                                                    "@upper_limit": "2.91", 
                                                    "@value": "2.29"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Blood samples were taken at 0 (pre-dose), 1, 2, 3, 4, 6, 8 and 12 hours post-ingestion of medication.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Geometric Mean", 
                                    "title": "Cmax of Abacavir on Twice Daily Dosing", 
                                    "units": "mg/L"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Week 0", 
                        "title": "Cmax of Abacavir on Twice Daily Dosing", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Blood samples were taken at 0 (pre-dose), 1, 2, 3, 4, 6, 8, 12 and 24 hours post-ingestion of medication", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "This is a single arm study. First intervention: PK assessment of Twice Daily Abacavir (Week 0) Second intervention: PK assessment of Once Daily Abacavir (Week 4)", 
                                "title": "Single Arm"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "18"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "9.89", 
                                                    "@upper_limit": "13.53", 
                                                    "@value": "11.57"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Blood samples were taken at 0 (pre-dose), 1, 2, 3, 4, 6, 8, 12 and 24 hours post-ingestion of medication", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Geometric Mean", 
                                    "title": "AUC(0-24) of Abacavir on Once Daily Dosing", 
                                    "units": "h*mg/L"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Week 4", 
                        "title": "AUC(0-24) of Abacavir on Once Daily Dosing", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Blood samples were taken at 0 (pre-dose), 1, 2, 3, 4, 6, 8, 12 and 24 hours post-ingestion of medication.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "This is a single arm study. First intervention: PK assessment of Twice Daily Abacavir (Week 0) Second intervention: PK assessment of Once Daily Abacavir (Week 4)", 
                                "title": "Single Arm"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "18"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "3.86", 
                                                    "@upper_limit": "5.67", 
                                                    "@value": "4.68"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Blood samples were taken at 0 (pre-dose), 1, 2, 3, 4, 6, 8, 12 and 24 hours post-ingestion of medication.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Geometric Mean", 
                                    "title": "Cmax of Abacavir on Once Daily Dosing", 
                                    "units": "mg/L"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Week 4", 
                        "title": "Cmax of Abacavir on Once Daily Dosing", 
                        "type": "Primary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": {
                        "@group_id": "P1", 
                        "description": "This is a single arm crossover study\nst intervention: PK assessment while on Twice Daily Abacavir\nnd intervention: PK assessment while on Once Daily Abacavir", 
                        "title": "Single Arm"
                    }
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "2", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "Lost samples from one PK Day"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "1", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "Vomiting after commencing once daily"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "2", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "PK curve incomplete"
                                }
                            ]
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "23", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "#text": "18 Children had two evaluable PK days", 
                                            "@count": "18", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "Two Evaluable PK Days"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "#text": "5 children had only one evaluable PK day.", 
                                            "@count": "5", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "One Evaluable PK Day Only"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "18", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "5", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "email": "silvia.forcat@ucl.ac.uk", 
                "name_or_title": "Trial manager", 
                "organization": "MRC Clinical Trials Unit at UCL", 
                "phone": "02076704825"
            }, 
            "reported_events": {
                "group_list": {
                    "group": {
                        "@group_id": "E1", 
                        "description": "This is a single arm study. Intervention 1: PK assessment while on Twice Daily Abacavir (Week 0) Intervention 2: PK assessment while on Once Daily Abacavir  (Week 4)", 
                        "title": "Abacavir Once Versus Twice Daily"
                    }
                }, 
                "serious_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "4", 
                                            "@subjects_at_risk": "23"
                                        }, 
                                        "sub_title": "Total, serious adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "23"
                                            }, 
                                            "sub_title": "Vomiting"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "23"
                                            }, 
                                            "sub_title": "Diarrhoea"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "23"
                                            }, 
                                            "sub_title": "Croup Infectious"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "23"
                                            }, 
                                            "sub_title": "Gastroenteritis Bacteria"
                                        }
                                    ]
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "23"
                                        }, 
                                        "sub_title": "Skin Laceration"
                                    }
                                }, 
                                "title": "Injury, poisoning and procedural complications"
                            }
                        ]
                    }
                }
            }
        }, 
        "completion_date": {
            "#text": "June 2009", 
            "@type": "Actual"
        }, 
        "condition": "HIV Infection", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Infants and children with confirmed presence of HIV-1 infection\n\n          -  Infants and children aged 3 to <36 months\n\n          -  Parents/guardians able and willing to give written, informed consent\n\n          -  Currently on combination ART including Abacavir (ABC) oral solution with or without\n             Lamivudine (3TC) oral solution, for at least 12 weeks and expected to stay on this\n             regimen for at least a further 12 weeks.\n\n          -  HIV-1 RNA viral load either;\n\n               -  suppressed HIV-1 RNA viral load (i.e. <400 copies/ml)\n\n               -  non-suppressed, but low, HIV-1 RNA viral load (i.e. 400-20 000 copies/ml). The\n                  non-suppressed children should have had a stable or decreasing HIV-1 RNA viral\n                  load prior to study entry and should be considered to be still gaining benefit\n                  from the current regimen\n\n          -  Stable or rising CD4+ cell percent prior to study entry and should not be expected to\n             fall within the next 12 weeks.\n\n        Exclusion Criteria:\n\n          -  Intercurrent illness\n\n          -  Receiving concomitant therapy except prophylactic antibiotics\n\n          -  Abnormal renal or liver function (grade 3 or above)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "36 Months", 
            "minimum_age": "3 Months"
        }, 
        "enrollment": {
            "#text": "23", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 25, 2013", 
        "firstreceived_results_date": "December 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01973439", 
            "org_study_id": "PENTA15", 
            "secondary_id": "2005-004433-18"
        }, 
        "intervention": [
            {
                "arm_group_label": "Abacavir Once versus Twice Daily", 
                "description": "Week 0", 
                "intervention_name": "Intervention 1: PK assessment while on Twice Daily Abacavir", 
                "intervention_type": "Other", 
                "other_name": [
                    "Ziagen", 
                    "ABC"
                ]
            }, 
            {
                "arm_group_label": "Abacavir Once versus Twice Daily", 
                "description": "Week 4", 
                "intervention_name": "Intervention 2: PK assessment while on Once Daily Abacavir", 
                "intervention_type": "Other", 
                "other_name": [
                    "Ziagen", 
                    "ABC"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Abacavir"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "HIV", 
            "Abacavir", 
            "Lamivudine", 
            "Pharmacokinetics"
        ], 
        "lastchanged_date": "February 3, 2014", 
        "link": {
            "url": "http://www.penta-id.org/hiv/penta-trials/penta-trials-publications/50-penta-15.html"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital Robert Debr\u00e9"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital Port Royal"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Munich", 
                        "country": "Germany"
                    }, 
                    "name": "Immundefekt-Ambulanz, Dr. von Haunersches Kinderspital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Padova", 
                        "country": "Italy", 
                        "zip": "35128"
                    }, 
                    "name": "Clinica Pediatrica, Universit\u00e0 di Padova"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Getafe", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital 12 de Octubre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Gregorio Maranon"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Birmingham Heartlands Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom"
                    }, 
                    "name": "St. Mary's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Evelina Children's Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Germany", 
                "Italy", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "PENTA15: Plasma Pharmacokinetic Study of Once Versus Twice Daily Abacavir as Part of Combination Antiretroviral Therapy in Children With HIV-1 Infection Aged 3 Months to <36 Months", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
                "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
                "Germany: Federal Institute for Drugs and Medical Devices"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "June 2008", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Blood samples were taken at 0 (pre-dose), 1, 2, 3, 4, 6, 8 and 12 hours post-ingestion of medication.", 
                "measure": "Area Under Curve (AUC) (0-24) of Abacavir on Twice Daily Dosing", 
                "safety_issue": "No", 
                "time_frame": "Week 0"
            }, 
            {
                "description": "Blood samples were taken at 0 (pre-dose), 1, 2, 3, 4, 6, 8 and 12 hours post-ingestion of medication.", 
                "measure": "Cmax of Abacavir on Twice Daily Dosing", 
                "safety_issue": "No", 
                "time_frame": "Week 0"
            }, 
            {
                "description": "Blood samples were taken at 0 (pre-dose), 1, 2, 3, 4, 6, 8, 12 and 24 hours post-ingestion of medication", 
                "measure": "AUC(0-24) of Abacavir on Once Daily Dosing", 
                "safety_issue": "No", 
                "time_frame": "Week 4"
            }, 
            {
                "description": "Blood samples were taken at 0 (pre-dose), 1, 2, 3, 4, 6, 8, 12 and 24 hours post-ingestion of medication.", 
                "measure": "Cmax of Abacavir on Once Daily Dosing", 
                "safety_issue": "No", 
                "time_frame": "Week 4"
            }
        ], 
        "reference": {
            "PMID": "20516550", 
            "citation": "Paediatric European Network for Treatment of AIDS (PENTA). Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36 months. Antivir Ther. 2010;15(3):297-305. doi: 10.3851/IMP1532."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01973439"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "PENTA Foundation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "PENTA Foundation", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2006", 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}